Wound care – technology licensing

Oxy Solutions is developing products that aim to address and improve treatment of chronic wounds. The products are a wound healing gel and a wound healing rinse.


Oxygen is essential for wound healing

One of the most common complaints within healthcare today is hard-to-heal wounds. Besides the patient burden, they also stand for a high cost within medical services. The main problem is that microbes infect the wound and thereby inhibit the wound healing process. Further, the optimism regarding the ability of antibiotics to efficiently handle infections has decreased due to the rising number of multi-resistant bacteria.

Oxygen is essential to life and in the wound healing process. It plays a key role in supporting tissue regeneration and repair by inhibiting anaerobic bacteria and supporting the body’s natural defense mechanism. Available research indicates that oxygen has a role as an anti-infective agent, in the reduction of biofilm formation, in increasing leukocytes microbicidal effect, and in potentiating the effects of several antimicrobial drugs on biofilm infections. In addition, it is well established that adequate oxygen supply is crucial for proper wound healing. There are few studies evaluating the effect of highly oxygenated wound dressings (or other oxygen therapies) on biofilm reduction or eradication. Thus, further studies are needed. The role of e.g. hyperbaric oxygen therapy as an anti-infective agent is, however, clearly evident.

Oxy Solutions wound healing products are based on a patent technology that ensures an elevated, controlled and stable level of oxygen that can be administered to hard-to-heal wounds. Research indicate that the formulation ensures oxygen penetration to the skin more effectively than current oxygen gas treatment. It also indicates improved wound healing properties such as wound closure, vascular density, collagen formation an leukocyte infiltration.

Licensing of technology

The technology platform has been testes in in a proof of concept using a delayed wound healing model with diabetic mice – The results from the study show increased wound healing compared to a marketed product used for chronic wounds. The results further show increased regeneration of capillaries with oxygen nanobubbles compared to the non-oxygenated control.

Contact us for information about licensing the technology platform, and how to integrate the technology into your existing portfolio, without cannibalizing existing products.

Study on Oxygen in gel
Oxygenated bioPolymers for biomedical applications
Oxygenated Nanocellulose - A Material Platform for Antibacterial Wound Dressing Devices